These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 22552293)

  • 21. Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma.
    Villanova T; Gesmundo I; Audrito V; Vitale N; Silvagno F; Musuraca C; Righi L; Libener R; Riganti C; Bironzo P; Deaglio S; Papotti M; Cai R; Sha W; Ghigo E; Schally AV; Granata R
    Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2226-2231. PubMed ID: 30659154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of platelet-derived growth factor (PDGF) and PDGF receptors in human malignant mesothelioma in vitro and in vivo.
    Langerak AW; De Laat PA; Van Der Linden-Van Beurden CA; Delahaye M; Van Der Kwast TH; Hoogsteden HC; Benner R; Versnel MA
    J Pathol; 1996 Feb; 178(2):151-60. PubMed ID: 8683381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Podoplanin promotes progression of malignant pleural mesothelioma by regulating motility and focus formation.
    Takeuchi S; Fukuda K; Yamada T; Arai S; Takagi S; Ishii G; Ochiai A; Iwakiri S; Itoi K; Uehara H; Nishihara H; Fujita N; Yano S
    Cancer Sci; 2017 Apr; 108(4):696-703. PubMed ID: 28182302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasion potential of H22 hepatocarcinoma cells is increased by HMGB1-induced tumor NF-κB signaling via initiation of HSP70.
    Gong W; Wang ZY; Chen GX; Liu YQ; Gu XY; Liu WW
    Oncol Rep; 2013 Sep; 30(3):1249-56. PubMed ID: 23836405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autocrine inhibitory influences of alpha-melanocyte-stimulating hormone in malignant pleural mesothelioma.
    Catania A; Colombo G; Carlin A; Garofalo L; Gatti S; Buffa R; Carboni N; Rosso L; Santambrogio L; Cantalamessa L; Lipton JM
    J Leukoc Biol; 2004 Feb; 75(2):253-9. PubMed ID: 14576363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Mobility Group Box-1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice.
    Ge X; Arriazu E; Magdaleno F; Antoine DJ; Dela Cruz R; Theise N; Nieto N
    Hepatology; 2018 Dec; 68(6):2380-2404. PubMed ID: 29774570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection.
    Suzuki E; Kim S; Cheung HK; Corbley MJ; Zhang X; Sun L; Shan F; Singh J; Lee WC; Albelda SM; Ling LE
    Cancer Res; 2007 Mar; 67(5):2351-9. PubMed ID: 17332368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesothelioma.
    Kalra N; Zhang J; Thomas A; Xi L; Cheung M; Talarchek J; Burkett S; Tsokos MG; Chen Y; Raffeld M; Miettinen M; Pastan I; Testa JR; Hassan R
    BMC Cancer; 2015 May; 15():376. PubMed ID: 25952750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
    Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
    Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma.
    Kadariya Y; Menges CW; Talarchek J; Cai KQ; Klein-Szanto AJ; Pietrofesa RA; Christofidou-Solomidou M; Cheung M; Mossman BT; Shukla A; Testa JR
    Cancer Prev Res (Phila); 2016 May; 9(5):406-414. PubMed ID: 26935421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SV40-dependent AKT activity drives mesothelial cell transformation after asbestos exposure.
    Cacciotti P; Barbone D; Porta C; Altomare DA; Testa JR; Mutti L; Gaudino G
    Cancer Res; 2005 Jun; 65(12):5256-62. PubMed ID: 15958571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High CD44 expression on human mesotheliomas mediates association with hyaluronan.
    Penno MB; Askin FB; Ma H; Carbone M; Vargas MP; Pass HI
    Cancer J Sci Am; 1995; 1(3):196-203. PubMed ID: 9166476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and clinical significance of HMGB1 in human liver cancer: Knockdown inhibits tumor growth and metastasis in vitro and in vivo.
    Dong YD; Cui L; Peng CH; Cheng DF; Han BS; Huang F
    Oncol Rep; 2013 Jan; 29(1):87-94. PubMed ID: 23042506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term exposure of mesothelial cells to SV40 and asbestos leads to malignant transformation and chemotherapy resistance.
    Cleaver AL; Bhamidipaty K; Wylie B; Connor T; Robinson C; Robinson BW; Mutsaers SE; Lake RA
    Carcinogenesis; 2014 Feb; 35(2):407-14. PubMed ID: 24130165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity.
    Chen M; Liu Y; Varley P; Chang Y; He XX; Huang H; Tang D; Lotze MT; Lin J; Tsung A
    Cancer Res; 2015 Apr; 75(8):1645-56. PubMed ID: 25720799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of Heparanase in the Pathogenesis of Mesothelioma: Basic Aspects and Clinical Applications.
    Barash U; Lapidot M; Zohar Y; Loomis C; Moreira A; Feld S; Goparaju C; Yang H; Hammond E; Zhang G; Li JP; Ilan N; Nagler A; Pass HI; Vlodavsky I
    J Natl Cancer Inst; 2018 Oct; 110(10):1102-1114. PubMed ID: 29579286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-Mobility Group Box 1 Is Associated with the Inflammatory Pathogenesis of Graves' Orbitopathy.
    Han SY; Choi SH; Shin JS; Lee EJ; Han SH; Yoon JS
    Thyroid; 2019 Jun; 29(6):868-878. PubMed ID: 30973094
    [No Abstract]   [Full Text] [Related]  

  • 38. HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration.
    Bassi R; Giussani P; Anelli V; Colleoni T; Pedrazzi M; Patrone M; Viani P; Sparatore B; Melloni E; Riboni L
    J Neurooncol; 2008 Mar; 87(1):23-33. PubMed ID: 17975708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High mobility group box 1 (HMGB1) protein in human uterine fluid and its relevance in implantation.
    Bhutada S; Basak T; Savardekar L; Katkam RR; Jadhav G; Metkari SM; Chaudhari UK; Kumari D; Kholkute SD; Sengupta S; Sachdeva G
    Hum Reprod; 2014 Apr; 29(4):763-80. PubMed ID: 24488797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.
    Suzuki Y; Sakai K; Ueki J; Xu Q; Nakamura T; Shimada H; Nakamura T; Matsumoto K
    Int J Cancer; 2010 Oct; 127(8):1948-57. PubMed ID: 20104519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.